Areas of Focus
- Multidrug Resistance
- Melanoma Treatment
- Chronic Myeloid Leukemia
- Epilepsy Treatment
- P-Glycoprotein Inhibition
Academic Background & Achievements
- PhD: Not mentioned
Publications
- The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance, Zhonglian Cao, Meredith Wright, Jiekai Cheng, Xiaoxing Huang, Li Liu, Lixing Wu, Ping Yang, 2014
- A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma, Kairong Shi, Jianping Li, Zhonglian Cao, Ping Yang, Yue Qiu, Bo Yang, Yang Wang, Yang Long, Yayuan Liu, Qianyu Zhang, Jun Qian, Zhirong Zhang, Huile Gao, Qin He, 2015
- Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells, Ping Song, Li Ye, Jiajun Fan, Yubin Li, Xian Zeng, Ziyu Wang, Shaofei Wang, Guoping Zhang, Ping Yang, Zhonglian Cao, Dianwen Ju, 2014
- Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy, Xiaoxing Huang, Hailong Zhang, Jun Yang, Jingfan Wu, John McMahon, Yufan Lin, Zhonglian Cao, Michael Gruentha, Yunfei Huang, 2010
- Effect of 5 Novel 5-Substituted Tetrandrine Derivatives on P-Glycoprotein-Mediated Inhibition and Transport in Caco-2 Cell, Zhonglian Cao, Dan Li, Li Liu, Ping Yang
- To screen P-glycoprotein inhibitors in Caco-2 cell-based permeability studies coupled with the high performance liquid chromatography, Zhonglian Cao, Xiaoxia Li, Xueling Liao, Ping Yang